Literature DB >> 28084622

Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S.

Arun Raghav Mahankali Sridhar1, Madhav Lavu2, Vivek Yarlagadda3, Madhu Reddy2, Sampath Gunda2, Rizwan Afzal2, Donita Atkins2, Rakesh Gopinathanair4, Buddhadeb Dawn2, Dhanunjaya R Lakkireddy2.   

Abstract

BACKGROUND: Implantation of cardiac implanted electronic device (CIED) has surged lately. This resulted in a rise in cardiac device-related infections (CDI) and inevitably, lead extractions. We examined the recent national trend in the incidence of CIED infections and lead extractions in hospitalized patients and associated mortality.
METHODS: Using the Nationwide Inpatient Sample for the years 2003-2011 we identified patients diagnosed with a CDI-associated infection as determined by discharge ICD-9 diagnostic codes. We examined the trend of device-related infections overall and in different subgroups. We studied mortality associated with device infections, lead extractions, associated costs, and length of stay.
RESULTS: There is a significant increase in the number of hospitalizations due to CDI from 5,308 in the year 2003 to 9,948 in 2011. Males (68%), Caucasians (77%), and age group 65-84 years (56.4%) accounted for majority of CDI. The mortality associated with CDI was 4.5 %, and was worse in higher age groups (2.5% in 18-44 years compared to 5.3% in 85+ years, P < 0.001). Average length of stay was unchanged over the years remaining at 13.6 days; however, mean hospitalization charges increased from $91,348 in 2003 to $173,211 in 2011 (P < 0.001). Among all lead extraction procedures, the percentage of patients undergoing lead extraction secondary to CDI also increased from 2003 (59.1%) to 2011 (76.7%), P-value < 0.001.
CONCLUSIONS: Healthcare burden associated with CDI infections and associated lead extractions has significantly increased in the recent years. Despite an increase in cost associated with CIED infections, mortality remains the same, and is higher in older patients.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac pacemaker; implantable cardioverter defibrillator; lead extraction; lead infection

Mesh:

Year:  2017        PMID: 28084622     DOI: 10.1111/pace.13009

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  12 in total

1.  Tricuspid Valve Leaflet Repair and Augmentation for Infective Endocarditis.

Authors:  Alexander A Brescia; Tessa M F Watt; Aaron M Williams; Matthew A Romano; Steven F Bolling
Journal:  Oper Tech Thorac Cardiovasc Surg       Date:  2019-10-25

Review 2.  The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment.

Authors:  Monica Parry; Harriette G C Van Spall; Kerri-Anne Mullen; Sharon L Mulvagh; Christine Pacheco; Tracey J F Colella; Marie-Annick Clavel; Shahin Jaffer; Heather J A Foulds; Jasmine Grewal; Marsha Hardy; Jennifer A D Price; Anna L E Levinsson; Christine A Gonsalves; Colleen M Norris
Journal:  CJC Open       Date:  2022-04-19

3.  Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial.

Authors:  François Philippon; Gilles E O'Hara; Jean Champagne; Stefan H Hohnloser; Michael Glikson; Jörg Neuzner; Philippe Mabo; Xavier Vinolas; Josef Kautzner; Fredrik Gadler; Noa Lashevsky; Stuart J Connolly; Yan Y Liu; Jeff S Healey
Journal:  CJC Open       Date:  2020-04-25

4.  Risk Profiles and Outcomes of Patients Receiving Cardiovascular Implantable Electronic Devices With and Without Antibacterial Envelopes.

Authors:  David A Woodard; Grace Kim; Kent R Nilsson
Journal:  Cureus       Date:  2022-05-04

Review 5.  Cardiac implantable electrical devices in women.

Authors:  Kalaimani Elango; Anne B Curtis
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

6.  Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.

Authors:  Hui-Chen Han; Nathaniel M Hawkins; Charles M Pearman; David H Birnie; Andrew D Krahn
Journal:  Europace       Date:  2021-06-23       Impact factor: 5.214

7.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

8.  Cardiac implantable electronic device infections: Observational data from a tertiary care center in Lebanon.

Authors:  Marwan Refaat; Patrick Zakka; Maurice Khoury; Hassan Chami; Shareef Mansour; Bernard Harbieh; Bernard Abi-Saleh; Abdul Rahman Bizri
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

9.  Lead Removal Without Extraction Tools: A Single-Center Experience.

Authors:  Neiberg de Alcantara Lima; Gisele Schinaider Cunha; Natalia Soares de Menezes; Evilásio Leobino da Silva; Carol Cavalcante de Vasconcelos Lima; Stela Maria Vitorino Sampaio
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27

10.  Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients.

Authors:  Myung Hwan Bae; Yongkeun Cho; Jongmin Hwang; Hyoung Seob Park; Seongwook Han; Young Soo Lee; Hyun Jun Cho; Byung Chun Jung; Chan Hee Lee; Dae Woo Hyun; Jong Sung Park; Jinhee Ahn; Ki Hun Kim; Dong Gu Shin
Journal:  J Korean Med Sci       Date:  2020-03-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.